XORTX Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Allen Warren Davidoff, with a market cap of $3.2M.
Common questions about XORTX Therapeutics Inc.
XORTX Therapeutics Inc. is scheduled to report earnings for Q1 2026 on May 15, 2026.
XORTX Therapeutics Inc. has approximately 3 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.